Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Clinical trial NCT06651970 · RECRUITING

Trial details

NCT number: NCT06651970
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukaemia Moderate to Severe Cardiac Impairment

Start date: 2025-02-04
Primary completion: 2030-08-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.